Recent Finacing
Recent Raise
Pharma Two B is a clinical-stage biopharmaceutical company that develops fixed‑dose combination oral formulations of approved drugs via the FDA 505(b)(2) pathway, focused on P2B001 for early-stage Parkinson’s.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
